UBS downgraded LexinFintech to Neutral from Buy with a price target of $3.50, down from $13.60. The firm cut estimates for the company citing a bigger earnings impact from the current asset quality cycle. It sees the LexinFintech shares being range-bound until the peaks of asset quality and regulatory cycles are confirmed, which is thinks is likely in Q1 of 2026.
